The full content will be available shortly. Thank you for your patience!
Lucy Salum-Rodríguez 1
, María F. Zalapa-Gómez 1
, Antonio Santillán-Gómez 2
, Andrés A. Santillán-González 3 
1 Departamento de Ginecología y Obstetricia, Programa Multicéntrico del Tecnológico de Monterrey, Secretaría de Salud de Nuevo León, Monterrey, Nuevo León, México; 2 Departamento de Ginecología Oncológica, Texas Oncology, San Antonio, Texas, Estados Unidos de América; 3 Ingeniería Biomédica, Facultad de la Universidad de Boston, Boston, Massachusetts, Estados Unidos de América
Lucy Salum-Rodríguez, María F. Zalapa-Gómez, Antonio Santillán-Gómez, Andrés A. Santillán-González
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Antonio Santillán-Gómez. Email: antonio.santillan@usoncology.com
Robotic surgery has transformed gynecologic oncologic surgical practice over the past two decades. The development of advanced systems such as the Da Vinci Xi, DV5 and SP, Hugo™ RAS, Versius®, and Senhance®, Hinotori, has expanded the capabilities of minimally invasive approaches, particularly in complex scenarios like surgical management of gynecological cancers. This review summarizes key technological advancements, discusses their clinical applicability, and compares robotic surgery with other surgical approaches (conventional laparoscopy and open surgery), with emphasis on quality of life, complications and oncology outcomes.
The full content will be available shortly. Thank you for your patience!